Dear Reader,

IAM will be hosting Pharma and Biotech IP Summit: Transforming Tactics into Optimal Strategies in Munich on November 3 2016.

As a valued Pharma Focus Asia reader, you can benefit from the exclusive discount of 20% (a saving of €180) on the full delegate rate of €895. Register here using the code SAVE180 before October 21.

This highly informative, content-driven forum, led by our world-class speaking faculty, will showcase practical solutions to the challenges facing life sciences, pharma and biotech companies, legal practitioners and other key stakeholders, including: 

• Understanding the DNA of business and formulating a successful IP strategy
• The current state of play with the Unified Patent Court and the European litigation landscape
• Scrutinising the European and US biologics environment
• Second medical use patents – the ongoing debate over their value

These and more topics will be discussed by:

• Jürgen Dressel, head of global patent litigation strategy, Novartis AG
• Fiona Bor, head of intellectual property, MorphoSys
• Bo Kalum, senior patent specialist, Lundbeck
• Gavin Lawson, senior manager, intellectual property, Gilead Sciences
• Henrik Mathiassen, director and head of IP department, Zealand Pharma
• Stephan Spiller, associate director, intellectual property, MorphoSys AG
• Adrian Spillmann, head of corporate intellectual property, Valneva

The full speaking faculty is available here.

Places are limited, so don’t delay – secure your place at Pharma and Biotech IP Summit 2016 today for just €715. Use code SAVE180 by October 21. 

Kind regards,

Joff Wild
Editor
IAM